Ophthalmology and COVID-19
Maximizing Care, Minimizing Risk
Like his colleagues across Wilmer, Neil Bressler is using an individualized approach to determine if — and when — his patients should come in to be seen.
Reopening Guided By Evidence-Based Protocols
As Wilmer reopened in June, evidence-based safety protocols guided the implementation of best practices for patient and employee safety.
COVID-19 Research Roundup
The latest on Wilmer's research efforts related to the COVID-19 pandemic.
Latest Wilmer News
Teaming Up for Surgically Complex Cases
Wilmer is among a handful of ophthalmology centers in the nation with the expertise to do 3 and 4 surgeries simultaneously.
Ready, Set, Launch
Teams of Wilmer faculty entrepreneurs, intent on turning their discoveries into new treatments, have created 13 new companies.
Moonshot: Collaborative Effort Targets Irreversible Blindness
Glaucoma specialist Thomas V. Johnson is co-leading a Johns Hopkins-based effort to regenerate the human optic nerve.
Building a Better Cornea
Wilmer researchers are working with materials science company W.L. Gore to change artificial corneas for the better.
Breazzano Brings Innovative Thinking to Wilmer
Retinal surgeon Mark Breazzano looks to some unlikely sources in his search for new approaches to treatments.
Implant Offers an Alternative to Eye Drops for Glaucoma Patients
A new implant alleviates the burden of multiple daily eye drops for patients with open-angle glaucoma and ocular hypertension.